Submission Details
| 510(k) Number | K192064 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 01, 2019 |
| Decision Date | October 02, 2019 |
| Days to Decision | 62 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K192064 is an FDA 510(k) clearance for the LIAISON Vitamin B12, a Radioassay, Vitamin B12 (Class II — Special Controls, product code CDD), submitted by DiaSorin, Inc. (Stillwater,, US). The FDA issued a Cleared decision on October 2, 2019, 62 days after receiving the submission on August 1, 2019. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1810.
| 510(k) Number | K192064 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 01, 2019 |
| Decision Date | October 02, 2019 |
| Days to Decision | 62 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CDD — Radioassay, Vitamin B12 |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1810 |